Logos Capital

Logos Capital

San Francisco based venture capital firm investing in biotechnology-based startups

Logos Capital is a San Francisco based venture capital firm investing in biotechnology-based startups. The company seeks to invest in in-house medical data analytics with scientific and clinical expertise to identify transformative therapies in life sciences and healthcare. It focuses on companies involved in new technologies and therapeutic approaches in molecular biology, bioinformatics, and genetic engineering, working towards our understanding of medicine and disease biology. Founded in 2019, the company has made four investments.

Timeline

Funded Companies

Company
Description
Website
Industry
Location

Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies.

Avidity Biosciences is a La Jolla-based company.

Repare Therapeutics is a Saint-Laurent, Quebec-based company.

3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Arsani William, MD MBA

Chief Investment Officer

Ed Callaway

Chief Operating Officer

Edward Zhong, PhD

Head of Data Science

Graham Walmsley, MD PhD

General Partner

Virginia Yee

Chief Financial Officer & Chief Compliance Officer

Yanni Souroutzidis, MBA

Head of Research

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.